ESMO 2026 Annual Congress (Madrid, Spain) Oct 23 - Oct 27, 2026 Supporting Materials Phase 1 Study of MGC026, a B7-H3–Targeted ADC in Advanced Solid Tumors 374.2 KB MGC026 Clinical Update (ESMO) 1.5 MB LINNET: A Phase 2 Study to Evaluate Lorigerlimab in Participants With Advanced Gynecologic Cancers 370.5 KB
LINNET: A Phase 2 Study to Evaluate Lorigerlimab in Participants With Advanced Gynecologic Cancers 370.5 KB
